Healthcare - Medical - Devices - NASDAQ - US
$ 2.84
-8.97 %
$ 13.5 M
Market Cap
-0.42
P/E
CASH FLOW STATEMENT
-11.9 M
OPERATING CASH FLOW
-853 K
INVESTING CASH FLOW
10.9 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Vivos Therapeutics, Inc.
| Net Income | -13.6 M |
| Depreciation & Amortization | 621 K |
| Capital Expenditures | -803 K |
| Stock-Based Compensation | 0 |
| Change in Working Capital | 2.86 M |
| Others | 27 K |
| Free Cash Flow | -12.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (13.6) | (23.8) | (20.3) | (12.1) | (10.8) | (8.4) |
| Depreciation & Amortization | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.6 |
| Deferred Income Tax | 0 | 0 | 1.1 | 0 | 60.3 K | 0 |
| Stock Based Compensation | 0 | 2.4 | 2.7 | 2.2 | 2.0 | 1.3 |
| Other Operating Activities | (1.8) | (0.5) | 9 K | 3.9 | 83.1 K | 0.4 |
| Change in Working Capital | 2.9 | 1.7 | 28 K | (0.4) | 2.5 | 0.9 |
| Cash From Operations | (11.9) | (19.6) | (15.7) | (5.7) | (5.3) | (5.3) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.8) | (0.9) | (2.4) | (0.1) | (0.2) | (1.3) |
| Other Items | 50 K | 0 | (0.2) | 0 | 0.3 | 0.1 |
| Cash From Investing Activities | (0.9) | (0.9) | (2.6) | (0.1) | 86.2 K | (1.1) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | (1.5) | (2.1) | (0.3) | (1.0) |
| Total Debt Repaid | 0 | 0 | 25 K | 1.2 | 3.7 | 88.2 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.1) | 0 | (3.7) | 56.9 K | 0.4 | (1.0) |
| Cash From Financing Activities | 10.9 | 0 | 24.2 | 23.5 | 4.5 | 5.3 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (1.9) | (20.5) | 5.8 | 17.7 | (0.8) | (1.2) |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (12.7) | (20.5) | (18.1) | (5.8) | (5.5) | (6.6) |